WuXi AppTec Co., Ltd. (603259.SS)
CNY 56.05
(-0.09%)
CNY 56.05
(-0.09%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 9.6 Billion CNY | 9.0% |
| 2022 | 8.81 Billion CNY | 72.91% |
| 2021 | 5.09 Billion CNY | 72.19% |
| 2020 | 2.96 Billion CNY | 59.62% |
| 2019 | 1.85 Billion CNY | -17.96% |
| 2018 | 2.26 Billion CNY | 84.22% |
| 2017 | 1.22 Billion CNY | 25.86% |
| 2016 | 974.98 Million CNY | 179.39% |
| 2015 | 348.96 Million CNY | -24.38% |
| 2014 | 461.5 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 2.29 Billion CNY | 18.3% |
| 2024 Q3 | 2.29 Billion CNY | -0.2% |
| 2024 Q1 | 1.94 Billion CNY | 26.91% |
| 2023 FY | 9.6 Billion CNY | 9.0% |
| 2023 Q4 | 1.53 Billion CNY | -44.62% |
| 2023 Q3 | 2.76 Billion CNY | -12.14% |
| 2023 Q1 | 2.16 Billion CNY | 51.0% |
| 2023 Q2 | 3.14 Billion CNY | 45.06% |
| 2022 Q2 | 2.99 Billion CNY | 82.16% |
| 2022 FY | 8.81 Billion CNY | 72.91% |
| 2022 Q4 | 1.43 Billion CNY | -47.64% |
| 2022 Q3 | 2.74 Billion CNY | -8.37% |
| 2022 Q1 | 1.64 Billion CNY | 7.04% |
| 2021 Q4 | 1.53 Billion CNY | 73.02% |
| 2021 FY | 5.09 Billion CNY | 72.19% |
| 2021 Q3 | 887.12 Million CNY | -24.52% |
| 2021 Q2 | 1.17 Billion CNY | -21.64% |
| 2021 Q1 | 1.49 Billion CNY | 153.4% |
| 2020 Q2 | 1.41 Billion CNY | 366.64% |
| 2020 Q1 | 303.04 Million CNY | 238.96% |
| 2020 FY | 2.96 Billion CNY | 59.62% |
| 2020 Q4 | 591.87 Million CNY | -9.11% |
| 2020 Q3 | 651.2 Million CNY | -53.95% |
| 2019 Q1 | 386.47 Million CNY | 16.36% |
| 2019 FY | 1.85 Billion CNY | -17.96% |
| 2019 Q4 | 89.4 Million CNY | -87.38% |
| 2019 Q3 | 708.38 Million CNY | 5.68% |
| 2019 Q2 | 670.28 Million CNY | 73.43% |
| 2018 Q3 | 656.47 Million CNY | -33.1% |
| 2018 Q1 | 290.65 Million CNY | 77.17% |
| 2018 Q2 | 981.23 Million CNY | 237.59% |
| 2018 FY | 2.26 Billion CNY | 84.22% |
| 2018 Q4 | 332.14 Million CNY | -49.4% |
| 2017 Q3 | 320.59 Million CNY | -20.95% |
| 2017 Q1 | 336.86 Million CNY | 0.0% |
| 2017 FY | 1.22 Billion CNY | 25.86% |
| 2017 Q4 | 164.05 Million CNY | -48.83% |
| 2017 Q2 | 405.57 Million CNY | 20.4% |
| 2016 FY | 974.98 Million CNY | 179.39% |
| 2015 FY | 348.96 Million CNY | -24.38% |
| 2014 FY | 461.5 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Shanghai Runda Medical Technology Co., Ltd. | 273.29 Million CNY | -3415.138% |
| Joinn Laboratories(China)Co.,Ltd. | 396.99 Million CNY | -2319.881% |
| Autobio Diagnostics Co., Ltd. | 1.21 Billion CNY | -689.095% |
| Thalys Medical Technology Group Inc. | -158.57 Million CNY | 6158.306% |
| Guangzhou Kingmed Diagnostics Group Co., Ltd. | 643.38 Million CNY | -1393.164% |
| Chemclin Diagnostics Co., Ltd. | 147.37 Million CNY | -6418.64% |